NEWS

BREAKING NEWS

PRESS RELEASE

Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Tech...

NASHVILLE, Tenn., (December 23, 2021) – Today, Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.

PRESS RELEASE

Wallaby Medical launches Avenir® Coil System for hemorrhagic stroke trea...

SHANGHAI, CHINA – December 27, 2021 -  Wallaby Medical (“Wallaby”), a rapidly growing medical device company focused on developing and commercializing medical device products for treating stroke has partnered with Japan Lifeline Co., Ltd. (“JLL”), a publicly-listed medical device manufacturer and distributor with 48 sales offices across Japan, to bring Wallaby’s Japan PMDA approved Avenir® Coil System to the Japanese market. Avenir is used in the intravascular embolization of intracranial aneurysms and other neurovascular malformations (such as arteriovenous malformations and arteriovenous fistulas), as well as arterial and venous embolization of peripheral blood vessels.

BREAKING NEWS

BREAKING NEWS

BREAKING NEWS

BREAKING NEWS